Pulse Biosciences (PLSE) Deferred Taxes (2015)

Pulse Biosciences' (PLSE) quarterly Deferred Taxes came in at -$518000.0 in Q4 2015, down 7.25% quarter-over-quarter from -$483000.0 in Q3 2015.

Pulse Biosciences (PLSE) Deferred Taxes (2015) Analysis & Trends

Pulse Biosciences' Deferred Taxes history runs 1 years deep, the most recent figure standing at -$518000.0 for Q4 2015.

On a quarterly basis, Deferred Taxes changed N/A year-over-year to -$518000.0 in Q4 2015; TTM through Dec 2015 was -$1.7 million, a N/A change from a year earlier, with the FY2015 full-year figure at -$1.7 million, down 7104.35% from the prior year.
Deferred Taxes retreated to -$518000.0 in Q4 2015 per PLSE's latest filing, from -$483000.0 in the prior quarter.
Across five years, Deferred Taxes topped out at -$299000.0 in Q1 2015 and bottomed at -$518000.0 in Q4 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Deferred Taxes (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn	-
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn	-31.00 Mn
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn	-73.00 Mn
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn	37.00 Mn
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn	-
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn	-
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn	43.50 Mn
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn	-41.00 Mn
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn	40.64 Mn
10	Pulse Biosciences	2.09 Bn	2.01 Bn	-	-

Download Data